Supplements
The Practitioner's Guide to Best Apigenin Supplement
Apigenin is quietly becoming one of the most talked-about longevity compounds in clinical circles — yet most people are still getting it from chamomile tea at doses 50 times too low to matter. Research now shows this plant-derived flavone targets CD38, the enzyme that degrades NAD+, while also activating GABA-A receptors to promote deep, restorative sleep. If you want the real benefits, the supplement you choose — its form, dose, and what it's paired with — makes all the difference.
What Is Apigenin and Why Is It Generating So Much Clinical Interest?
Apigenin (4′,5,7-trihydroxyflavone) is a naturally occurring flavone found in parsley, celery, chamomile, and many other plant foods. It has been studied for decades in preclinical models for its anti-inflammatory, anxiolytic, and potential anti-cancer properties, but it has entered mainstream health conversations primarily through two mechanisms that matter to longevity-focused practitioners and biohackers alike.
First, apigenin is a potent inhibitor of CD38, a NAD-consuming enzyme that becomes increasingly overactive with age. CD38 activity is now recognized as one of the primary drivers of the age-related decline in cellular NAD+ levels (Camacho-Pereira et al., Cell Metabolism 2016; PMID: 27304509). By suppressing CD38, apigenin theoretically spares intracellular NAD+ — a concept that aligns with broader NMN and NR supplementation strategies, though apigenin acts upstream at the enzyme level rather than by adding precursor substrate.
Second, apigenin binds to benzodiazepine receptors on the GABA-A complex as a partial agonist, producing mild anxiolytic and sedative effects without the dependency profile of prescription benzodiazepines (Viola et al., Planta Medica 1995; PMID: 7617760). This is why 50 mg of apigenin taken at night has become a staple in sleep optimization protocols discussed by researchers and clinicians.
The challenge is getting a therapeutic dose. A cup of chamomile tea delivers roughly 0.5–1 mg of apigenin — a fraction of what the literature suggests is needed. Choosing the best apigenin supplement means understanding bioavailability, form, dose standardization, and the synergistic ingredients it should be paired with.
---
Apigenin Bioavailability: Why Form and Delivery Matter
Free apigenin (aglycone form) is the most bioavailable form when taken orally, but it is still considered poorly water-soluble. Studies in human subjects show that absorption is highly variable and strongly influenced by the food matrix and gut microbiome composition (Nielsen et al., Journal of Nutrition 1999; PMID: 10395587). Glycoside-bound forms — found naturally in plant foods — must be cleaved by intestinal bacteria before the aglycone can be absorbed, which creates inter-individual variability.
For supplementation purposes, the key quality markers to look for are:
| Feature | What to Look For | Why It Matters |
|---|---|---|
| Form | Free aglycone (apigenin, not apigenin-7-glucoside) | Higher direct absorption potential |
| Dose | 50 mg per serving | Matches protocols used in human-relevant research |
| Standardization | ≥98% purity by HPLC | Ensures you're getting actual apigenin, not chamomile extract filler |
| Encapsulation | Lipid-based or with phospholipids | Can enhance absorption of this fat-soluble flavone |
| Third-party testing | USP, NSF, or ISO-accredited lab | Verifies label accuracy and absence of contaminants |
Some manufacturers now offer liposomal apigenin or apigenin complexed with phosphatidylcholine, though direct human pharmacokinetic comparisons between these delivery systems are still limited in the published literature. Until more head-to-head data exist, a high-purity free aglycone at 50 mg from a third-party tested source remains the most evidence-supported choice.
---
What Does the Human Evidence Actually Say?
It's important to distinguish between robust human clinical trials and the preclinical literature, which is far more extensive for apigenin. Most of the mechanistic data come from cell and animal studies, and extrapolation to humans requires appropriate caution.
That said, several findings are clinically meaningful:
Sleep and anxiety: A double-blind, placebo-controlled trial of an apigenin-rich chamomile extract (270 mg standardized to apigenin) in 34 patients with generalized anxiety disorder demonstrated significant improvement in Hamilton Anxiety (HAM-A) scores compared to placebo (Amsterdam et al., Journal of Clinical Psychopharmacology 2009; PMID: 19593179). While this used a chamomile extract rather than isolated apigenin, the investigators attributed primary bioactivity to the apigenin content.
NAD+ preservation: The CD38 inhibition data underpinning apigenin's role in NAD+ biology is primarily from rodent models (Camacho-Pereira et al., 2016). Human trials directly measuring apigenin's effect on cellular NAD+ remain sparse as of this writing. Clinicians interested in NAD+ support should treat apigenin as a complementary strategy rather than a standalone NAD+ intervention.
Inflammation: Apigenin has demonstrated inhibition of NF-κB signaling and prostaglandin synthesis in vitro and in animal models. Human anti-inflammatory trials using isolated apigenin are limited, though the compound's safety profile at doses up to 200 mg/day appears benign in the published literature (NIH Office of Dietary Supplements, Natural Medicines database review).
Potential interactions: Apigenin inhibits CYP1A2 and CYP2C9 enzymes in vitro, which could theoretically affect the metabolism of certain medications. Anyone on anticoagulants, NSAIDs, or narrow-therapeutic-index drugs should consult their healthcare provider before adding apigenin.
---
Andrew Huberman Supplement List: How Apigenin Became a Household Name
No discussion of apigenin's rise in mainstream health culture is complete without acknowledging its appearance on what is broadly referred to as the Andrew Huberman supplement list — the publicly documented supplement stack discussed on the Huberman Lab podcast by Stanford neuroscientist Andrew Huberman, Ph.D.
Huberman has repeatedly cited 50 mg of apigenin taken approximately 30–60 minutes before bed as part of his sleep protocol, alongside magnesium threonate and L-theanine. The rationale he articulates aligns with the GABA-A agonism literature: apigenin's partial agonism at benzodiazepine receptors promotes sleep onset without the receptor downregulation or dependency risks associated with pharmaceutical GABA modulators.
This public endorsement from a credentialed neuroscientist drove extraordinary consumer demand and, unfortunately, a proliferation of low-quality apigenin products — many standardized to chamomile extract at doses that deliver only trace amounts of actual apigenin. The lesson for consumers: verify that the supplement label specifies milligrams of apigenin (not chamomile extract weight), with a purity specification.
If you're building a sleep stack inspired by this approach, pairing apigenin with magnesium glycinate for sleep support is a well-supported combination. Magnesium's role in GABA-receptor activation complements apigenin's partial agonism, and magnesium glycinate specifically has a gentler GI profile than oxide or citrate forms.
---
Korean Ginseng Supplement: A Complementary Adaptogen for Apigenin Stacks
While apigenin operates primarily through GABA-A modulation and CD38 inhibition, many of the same consumers seeking apigenin are also interested in daytime energy, cognitive performance, and HPA-axis regulation — areas where a Korean ginseng supplement (Panax ginseng, standardized to ginsenosides) has a substantive evidence base.
Panax ginseng (Korean red ginseng) has been evaluated in randomized controlled trials for cognitive function, fatigue, and immune modulation. A systematic review of 10 RCTs found that Panax ginseng improved working memory and reaction time in healthy adults, with effects most pronounced at doses of 200–400 mg standardized extract (Geng et al., Journal of Alzheimer's Disease 2010; PMID: 20182023).
The synergy logic is straightforward: apigenin at night supports sleep quality and GABA-mediated recovery; Panax ginseng in the morning supports daytime resilience through ginsenoside-mediated modulation of the HPA axis and nitric oxide pathways. They do not interact pharmacologically in any documented way, and their temporal separation (apigenin PM, ginseng AM) makes the combination practical.
For those curious about a broader adaptogen stack, the clinical evidence for ashwagandha is another logical reference point — ashwagandha's cortisol-reducing properties, validated at 600 mg KSM-66 in a double-blind RCT (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798), complement both ginseng and apigenin depending on whether the primary goal is performance or recovery.
---
Alpha GPC Choline Supplement: The Cognitive Pairing Worth Understanding
Another ingredient that frequently appears alongside apigenin in biohacker stacks is alpha GPC (alpha-glycerylphosphorylcholine), a choline-containing phospholipid that serves as a highly bioavailable acetylcholine precursor. If apigenin's primary role is sleep and NAD+ biology, alpha GPC's primary role is cholinergic support for focus, memory encoding, and physical power output.
A randomized trial in 73 Alzheimer's patients found that alpha GPC (1,200 mg/day) significantly improved Alzheimer's Disease Assessment Scale cognitive subscale scores versus placebo over 180 days (De Jesus Moreno Moreno, Clinical Therapeutics 2003; PMID: 12637119). In healthy younger adults, 400–600 mg before exercise has been shown to increase growth hormone secretion and peak power output (Ziegenfuss et al., Journal of the International Society of Sports Nutrition 2008; PMID: 18616418).
The practical stack architecture that emerges from the literature is layered: apigenin (50 mg) at night for sleep and recovery; an alpha GPC choline supplement (300–600 mg) in the morning for cholinergic cognitive support; and a NAD+ precursor or CD38 inhibitor strategy for longevity. These compounds operate through distinct, non-overlapping mechanisms, which minimizes interaction risk and allows each to work in its intended context.
---
Best Sulforaphane Supplement: The Nrf2 Partner to Apigenin's CD38 Work
The best sulforaphane supplement conversation is directly relevant to anyone pursuing the apigenin + NAD+ pathway, because sulforaphane operates through a complementary but distinct longevity mechanism: Nrf2 pathway activation.
Sulforaphane, derived from broccoli sprout extract, activates Nrf2 (nuclear factor erythroid 2-related factor 2), the master regulator of cellular antioxidant defense and detoxification gene expression. In a human trial, 3 days of broccoli sprout consumption significantly induced Nrf2 target genes in peripheral blood mononuclear cells, with effects correlating with sulforaphane metabolite levels (Gasper et al., Molecular Nutrition & Food Research 2005; PMID: 16265671).
Where apigenin inhibits CD38 to spare NAD+ from enzymatic degradation, sulforaphane reduces oxidative stress load upstream — meaning less NAD+ is consumed in reactive oxygen species (ROS) defense. The two compounds are therefore mechanistically additive in the context of cellular NAD+ economy and longevity biology.
For sulforaphane supplements specifically, look for products standardized to glucoraphanin with active myrosinase enzyme (to facilitate conversion to active sulforaphane), or products that deliver pre-converted sulforaphane directly. Dose ranges in human studies have varied from 20–200 µmol per day; a common effective dose is approximately 40–60 µmol. Understanding omega-3 EPA DHA ratios alongside sulforaphane is also worthwhile, as omega-3 fatty acids and Nrf2 activators appear to have overlapping anti-inflammatory downstream effects.
---
How Ones Addresses This: Building Apigenin Into a Personalized Formula
For most people, the challenge isn't knowing that apigenin is interesting — it's figuring out how it fits within a broader, individualized supplement strategy without duplicating mechanisms, exceeding safe tolerances, or wasting capsule space on compounds that don't match your specific biomarkers.
Ones approaches this by analyzing your blood work, wearable data, and health history through an AI health practitioner framework, then building a custom capsule formula from a curated catalog of clinically validated ingredients. Here's how three specific ingredients intersect with the apigenin discussion:
1. Apigenin (50 mg): Where your data and goals support sleep optimization or NAD+ preservation, Ones can include apigenin at the 50 mg dose referenced in the GABA-A agonism and CD38 inhibition literature — not a chamomile extract approximation, but the standardized flavone at a dose that matches what the evidence supports.
2. Magnesium Glycinate (as part of Magnesium Complex): Ones includes magnesium glycinate within its proprietary Magnesium Complex blend, which pairs naturally with apigenin for sleep support. Magnesium's role in GABA receptor function is well-established, and the glycinate chelate is better tolerated and more bioavailable than inorganic forms. This is particularly relevant for users whose wearable data shows poor sleep architecture or whose labs reveal low serum or RBC magnesium.
3. Ashwagandha KSM-66 (600 mg): For users with elevated cortisol markers, disrupted HRV on wearables, or flagged stress physiology, Ones includes Ashwagandha as KSM-66 at the 600 mg dose validated in the Chandrasekhar 2012 RCT. KSM-66 is the most studied full-spectrum root extract, and its inclusion complements apigenin's GABA-mediated sleep support by addressing upstream HPA-axis dysregulation — the root cause that apigenin alone doesn't resolve.
If your 6-, 9-, or 12-capsule formula has room, Ones' AI will prioritize the ingredients with the highest signal-to-noise ratio for your specific data — meaning apigenin earns a slot when sleep, recovery, or NAD+ biology flags appear, not as a default.
You can also explore vitamin D3 and K2 synergy in the context of Ones formulas, since vitamin D status influences immune tone and inflammation — domains that interact with the same pathways apigenin modulates.
---
Key Takeaways
- Dose is everything: Chamomile tea delivers <1 mg of apigenin per cup. Effective supplementation requires 50 mg of standardized free-form apigenin (aglycone), not a chamomile extract weight approximation.
- Two validated mechanisms: Apigenin inhibits CD38 (sparing NAD+) and partially agonizes GABA-A benzodiazepine receptors (supporting sleep onset) — distinct pathways that explain its dual popularity in longevity and sleep optimization circles.
- Form and purity matter: Look for ≥98% purity by HPLC, free aglycone form, and third-party testing. Avoid products that only list "chamomile extract" without specifying apigenin content in milligrams.
- Strategic pairing amplifies benefits: Magnesium glycinate (GABA support), sulforaphane (Nrf2/NAD+ synergy), and ashwagandha KSM-66 (HPA-axis modulation) are the most mechanistically logical co-supplements.
- CYP enzyme interactions are a real consideration: Apigenin inhibits CYP1A2 and CYP2C9 in vitro; anyone on medications metabolized by these enzymes should consult a healthcare provider before use.
- Personalized context wins: Apigenin is not a universal first-line supplement. Its value depends on your sleep data, NAD+ biology markers, and existing stack — which is exactly the kind of individualized assessment a platform like Ones is built to provide.